Verfahren zur Früherkennung kolorektaler Neoplasien

Das kolorektale Karzinom zählt mit fast 2 Millionen Neuerkrankungen und nahezu 1 Million Sterbefällen pro Jahr zu den häufigsten Krebserkrankungen weltweit. Durch die Einführung der Vorsorgekoloskopie ist die Inzidenz deutlich zurückgegangen. Mittlerweile gibt es unterschiedliche Verfahren, die der Früherkennung von Darmkrebs dienen. Diese Beitrag vermittelt eine Übersicht über die Anwendung und die sinnvolle Auswahl dieser Präventivmaßnahmen.

Schlüsselwörter

Screening - Darmkrebsvorsorge - Früherkennung - Koloskopie - Stuhltest

• Literatur

• 1 Zentrum für Krebsregisterdaten, Robert Koch-Institut. Darmkrebs ICD-10 C18-C20. Zugriff am 05. Juni 2023 unter: https://www.krebsdaten.de/Krebs/DE/Content/Krebsarten/Darmkrebs/darmkrebs_node.html
• 2 Cardoso R, Zhu A, Guo F. et al. Inzidenz und Mortalität proximaler und distaler kolorektaler Karzinome in Deutschland. Dtsch Arztebl 2021; 118: 281-287
• 3 Kretschmann J, El Mahi C, Lichtner F. et al. Früherkennungskoloskopie. Jahresbericht 2018. Zentralinstitut für die kassenärztliche Versorgung in Deutschland. Zugriff am 05. Juni 2023 unter: https://www.zi.de/das-zi/medien/medieninformationen-und-statements/detailansicht/10-juli-2020
• 4 Heisser T, Hoffmeister M, Tillmanns H. et al. Impact of demographic changes and screening colonoscopy on long-term projection of incident colorectal cancer cases in Germany: A modelling study. Lancet Reg Health Eur 2022; 20: 100451
• 5 Imperiale TF, Gruber RN, Stump TE. et al. Performance Characteristics of Fecal Immunochemical Tests for Colorectal Cancer and Advanced Adenomatous Polyps: A Systematic Review and Meta-analysis. Ann Intern Med 2019; 170: 319-329
• 6 Ladabaum U, Dominitz JA, Kahi C. et al. Strategies for Colorectal Cancer Screening. Gastroenterology 2020; 158: 418-432
• 7 Knudsen AB, Rutter CM, Peterse EFP. et al. Colorectal Cancer Screening: An Updated Modeling Study for the US Preventive Services Task Force. JAMA 2021; 325: 1998-2011
• 8 Shaukat A, Levin TR. Current and future colorectal cancer screening strategies. Nat Rev Gastroenterol Hepatol 2022; 19: 521-531
• 9 Zorzi M, Hassan C, Capodaglio G. et al. Divergent Long-Term Detection Rates of Proximal and Distal Advanced Neoplasia in Fecal Immunochemical Test Screening Programs: A Retrospective Cohort Study. Ann Intern Med 2018; 169: 602-609
• 10 Chiu HM, Jen GH, Wang YW. et al. Long-term effectiveness of faecal immunochemical test screening for proximal and distal colorectal cancers. Gut 2021; 70: 2321-2329
• 11 Toes-Zoutendijk E, van Leerdam ME, Dekker E. et al. Real-Time Monitoring of Results During First Year of Dutch Colorectal Cancer Screening Program and Optimization by Altering Fecal Immunochemical Test Cut-Off Levels. Gastroenterology 2017; 152: 767-775
• 12 Gruner LF, Amitay EL, Heisser T. et al. The Effects of Different Invitation Schemes on the Use of Fecal Occult Blood Tests for Colorectal Cancer Screening: Systematic Review of Randomized Controlled Trials. Cancers (Basel) 2021; 13: 1520
• 13 Baxter NN, Warren JL, Barrett MJ. et al. Association between colonoscopy and colorectal cancer mortality in a US cohort according to site of cancer and colonoscopist specialty. J Clin Oncol 2012; 30: 2664-2669
• 14 Bretthauer M, Løberg M, Wieszczy P. et al. Effect of Colonoscopy Screening on Risks of Colorectal Cancer and Related Death. N Engl J Med 2022; 387: 1547-1556
• 15 Schwarz S, Schäfer W, Horenkamp-Sonntag D. et al. Follow-up of 3 Million Persons Undergoing Colonoscopy in Germany: Utilization of Repeat Colonoscopies and Polypectomies Within 10 Years. Clin Transl Gastroenterol 2020; 12: e00279
• 16 Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF). S3-Leitlinie Kolorektales Karzinom, Langversion 2.1, 2019, AWMF Registrierungsnummer: 021/007OL. Zugriff am 05. Juni 2023 unter: https://www.leitlinienprogramm-onkologie.de/leitlinien/kolorektales-karzinom/
• 17 Rex DK, Adler SN, Aisenberg J. et al. Accuracy of capsule colonoscopy in detecting colorectal polyps in a screening population. Gastroenterology 2015; 148: 948-957
• 18 Pecere S, Senore C, Hassan C. et al. Accuracy of colon capsule endoscopy for advanced neoplasia. Gastrointest Endosc 2020; 91: 406-414
• 19 Pickhardt PJ, Choi JR, Hwang I. et al. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med 2003; 349: 2191-2200
• 20 Johnson CD, Chen MH, Toledano AY. et al. Accuracy of CT colonography for detection of large adenomas and cancers. N Engl J Med 2008; 359: 1207-1217
• 21 Gluck N, Shpak B, Brun R. et al. A novel prepless X-ray imaging capsule for colon cancer screening. Gut 2016; 65: 371-373
• 22 Graser A, Melzer A, Lindner E. et al. Magnetic resonance colonography for the detection of colorectal neoplasia in asymptomatic adults. Gastroenterology 2013; 144: 743-750
• 23 Imperiale TF, Ransohoff DF, Itzkowitz SH. et al. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med 2014; 370: 1287-1297
• 24 Potter NT, Hurban P, White MN. et al. Validation of a real-time PCR-based qualitative assay for the detection of methylated SEPT9 DNA in human plasma. Clin Chem 2014; 60: 1183-1191
• 25 Johnson DA, Barclay RL, Mergener K. et al. Plasma Septin9 versus fecal immunochemical testing for colorectal cancer screening: a prospective multicenter study. PLoS One 2014; 9: e98238
• 26 Cohen JD, Li L, Wang Y. et al. Detection and localization of surgically resectable cancers with a multi-analyte blood test. Science 2018; 359: 926-930
• 27 Klein EA, Richards D, Cohn A. et al. Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set. Ann Oncol 2021; 32: 1167-1177
• 28 Poore GD, Kopylova E, Zhu Q. et al. Microbiome analyses of blood and tissues suggest cancer diagnostic approach. Nature 2020; 579: 567-574
• 29 Zwezerijnen-Jiwa FH, Sivov H, Paizs P. et al. A systematic review of microbiome-derived biomarkers for early colorectal cancer detection. Neoplasia 2023; 36: 100868
• 30 Young C, Wood HM, Fuentes Balaguer A. et al. Microbiome Analysis of More Than 2,000 NHS Bowel Cancer Screening Programme Samples Shows the Potential to Improve Screening Accuracy. Clin Cancer Res 2021; 27: 2246-2254
• 31 Jeon J, Du M, Schoen RE. et al. Determining Risk of Colorectal Cancer and Starting Age of Screening Based on Lifestyle, Environmental, and Genetic Factors. Gastroenterology 2018; 154: 2152-2164.e19
• 32 Archambault AN, Jeon J, Lin Y. et al. Risk Stratification for Early-Onset Colorectal Cancer Using a Combination of Genetic and Environmental Risk Scores: An International Multi-Center Study. J Natl Cancer Inst 2022; 114: 528-539
• 33 National Cancer Institute. The Colorectal Cancer Risk Assessment Tool. 05.06.2023 Zugriff am 02. Mai 2023 unter: https://ccrisktool.cancer.gov/